Nephrology
Episodes 33-48 of 51
Thilo Krüger, MD, PhD
Steven Fishbane, MD
Lucio Manenti, MD, PhD
Tessa Laubscher, MBChB, CCFP, FCFP
George L. Bakris, MD, FAHA, FASN
Mikhail Kosiborod, MD
Jonathan Barratt, PhD
Annette Bruchfeld, MD, PhD
Piotr Ponikowski, MD, PhD, FESC, FHFA
Robert J. Mentz, MD, FHFSA, FACC, FAHA
Ileana L. Piña, MD, MPH, FAHA, FACC
Javed Butler, MD, MBA, MPH
Patrick Rossignol, MD, PhD
Joel Topf, MD
Kieran McCafferty, MD
Jonathan Barratt, PhD
Donald E. Kohan, MD, PhD
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Antoine Lanot, MD, PhD
- KDIGO Conversations in Nephrology
Recent Progress in the Treatment of AAV and its Impact on the Outcome of the Patients
Vladimir Tesar, MD
David Jayne, MD
- KDIGO Conversations in Nephrology
Challenges in the Early Diagnosis of AAV
Vladimir Tesar, MD
Duvuru Geetha, MD
- KDIGO Conversations in Nephrology
Is There Still Any Role for Plasma Exchange in AAV?
Vladimir Tesar, MD
Michael Walsh, MD
- KDIGO Conversations in Nephrology
Best Practices in Fluid Management During CKRT
Marlies Ostermann, MD
Javier Neyra, MD, MSCS
- KDIGO Conversations in Nephrology
The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT Patients
Marlies Ostermann, MD
Rinaldo Bellomo, MBBS, MD, FRACP
- KDIGO Conversations in Nephrology
Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKI
Marlies Ostermann, MD
Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP
- Global Heart Failure Academy
AFFIRM-AHF: Key Takeaways
Ewa A. Jankowska, MD, PhD, FESC
- Global Heart Failure Academy
Late-breaking First Response on AFFIRM-AHF
Stefan D. Anker, MD, PhD
Javed Butler, MD, MBA, MPH
Ewa A. Jankowska, MD, PhD, FESC
Josep Comin-Colet, MD, PhD